SEC Form 4 · accession 0000914190-19-000023
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alisa Lask
Director
Period of report
Feb 8, 2019
Accepted (ET)
Feb 12, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $0.58 | Feb 8, 2019 | A | 70,817 | A | — | Feb 8, 2029 | Common Stock | 70,817 | 70,817 | D |
Explanation of responses
- F1On February 8, 2019, the Company granted to Ms. Lask an option to purchase 70,817 shares of common stock of the Company, of which one-third vested immediately upon the grant date, one-third will vest on the first anniversary of the grant date, and the remaining one-third will vest on the second anniversary of the grant date.